• Every cancer patient enters remission after drug trial, study reveals

    From Mr. Wayne@21:1/5 to All on Thu Jun 23 07:37:57 2022
    XPost: talk.politics.guns, soc.retirement, alt.fan.rush-limbaugh
    XPost: sac.politics

    A recent drug trial administered to a handful of cancer patients had the surprising result of eliminating the disease in every participant
    involved.

    The study was conducted on 18 rectal cancer patients at Memorial Sloan Kettering Cancer Center in Manhattan and had a 100 percent success rate, according to a paper published Sunday in the New England Journal of
    Medicine.

    “I believe this is the first time this has happened in the history of
    cancer,” Dr. Luis A. Diaz Jr, the author of the paper, told the New York
    Times.

    The drug, dostarlimab, was administered to each patient every 3 weeks for
    6 months.

    The drug trial was expected to be followed by chemotherapy and surgery, as
    is standard, for every participant.

    Some patients may have even required surgery leading to bowel and urinary dysfunction — or be forced to use a colostomy bag due to treatment, the
    Times said.

    However, since all patients had no evidence of a tumor after taking an
    MRI, rectal examination or a biopsy they were spared the agony of
    potentially damaging treatment.

    “There were a lot of happy tears,” Dr. Andrea Cercek, an oncologist at
    Memorial Sloan Kettering Cancer Center told the Times.

    In addition to not needing further treatment, there were no instances of a recurrence of cancer in the patients during follow-up appointments from 6
    to 25 months after the trial ended.

    One participant, Sascha Roth, told the Times that she planned to move to Manhattan for chemotherapy and radiation treatment.

    Then doctors gave her the good news — the trial worked and she was cancer- free.

    “I told my family,” Roth said. “They didn’t believe me.”

    https://nypost.com/2022/06/06/every-cancer-patient-enters-remission-after- drug-trial/

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From governor.swill@gmail.com@21:1/5 to All on Fri Jun 24 01:58:44 2022
    XPost: talk.politics.guns, soc.retirement, alt.fan.rush-limbaugh
    XPost: sac.politics

    On Thu, 23 Jun 2022 07:37:57 -0000 (UTC), "Mr. Wayne"
    <edge@fullerton.edu> wrote:

    I read about this a couple of weeks ago. The patients had a very
    specific condition, "mismatch repair deficient (dMMR) recurrent or
    advanced solid tumors". https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dostarlimab-gxly-dmmr-advanced-solid-tumors

    In the article I read, the drug can be modified to target different
    kinds of cancers.

    Swill



    A recent drug trial administered to a handful of cancer patients had the >surprising result of eliminating the disease in every participant
    involved.

    The study was conducted on 18 rectal cancer patients at Memorial Sloan >Kettering Cancer Center in Manhattan and had a 100 percent success rate, >according to a paper published Sunday in the New England Journal of
    Medicine.

    “I believe this is the first time this has happened in the history of >cancer,” Dr. Luis A. Diaz Jr, the author of the paper, told the New York >Times.

    The drug, dostarlimab, was administered to each patient every 3 weeks for
    6 months.

    The drug trial was expected to be followed by chemotherapy and surgery, as
    is standard, for every participant.

    Some patients may have even required surgery leading to bowel and urinary >dysfunction — or be forced to use a colostomy bag due to treatment, the
    Times said.

    However, since all patients had no evidence of a tumor after taking an
    MRI, rectal examination or a biopsy they were spared the agony of
    potentially damaging treatment.

    “There were a lot of happy tears,” Dr. Andrea Cercek, an oncologist at >Memorial Sloan Kettering Cancer Center told the Times.

    In addition to not needing further treatment, there were no instances of a >recurrence of cancer in the patients during follow-up appointments from 6
    to 25 months after the trial ended.

    One participant, Sascha Roth, told the Times that she planned to move to >Manhattan for chemotherapy and radiation treatment.

    Then doctors gave her the good news — the trial worked and she was cancer- >free.

    “I told my family,” Roth said. “They didn’t believe me.”

    https://nypost.com/2022/06/06/every-cancer-patient-enters-remission-after- >drug-trial/
    --
    Fostergate, CattleFuturesgate, Travelgate,
    Filegate, Troopergate, Whitewater, BenghaziGate,
    EmailGate, Uraniumgate - the list of GOP manufactured "scandals"
    involving Hillary that have never amounted to
    anything goes back for decades. The rightwing fear
    of her just goes on and on............
    - On "Hillarygate" from Usenet poster

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)